TMCnet News

Research and Markets: Future Horizons and Growth Strategies in the European Blood Banking Market 2014
[September 05, 2014]

Research and Markets: Future Horizons and Growth Strategies in the European Blood Banking Market 2014


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/66z7bm/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the European Blood Banking Market 2014: Supplier Shares and Country Forecasts" report to their offering.

"2014 Opportunities in the European Blood Banking Market" is a new five-country strategic analysis prepared by the author in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologes, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.



The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations


  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Key Topics Covered:

I. Introduction

II. Major Product Development Opportunities

III. Alternative Market Penetration Strategies

IV. Potential Market Entry Barriers and Risks

V. Worldwide Technology and Market Overview

VI. France A. Executive Summary

VII. Germany A. Executive Summary

VIII. Italy A. Executive Summary

IX. Spain A. Executive Summary

X. U.K. A. Executive Summary

XI. Competitive Assessments

  • Abbott
  • Beckman Coulter/Danaher (News - Alert)
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • Grifols
  • Immucor
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Orchid CellMark
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens (News - Alert)
  • Tecan

For more information visit http://www.researchandmarkets.com/research/66z7bm/future_horizons


[ Back To TMCnet.com's Homepage ]